Drug Trial Radar · NCT06568237
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
349
Actual
Start
Oct 2, 2024
Primary completion
Sep 15, 2027
Study completion Sep 15, 2027
Sponsor
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D LLCTeva (TEVA)
- Sponsor type
- Industry
- First posted
- Aug 23, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 30 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to evaluate the efficacy of TEV-56286 administered orally for the treatment of adult participants with Multiple System Atrophy (MSA). A secondary objective of the study is to evaluate specific efficacy parameters of TEV-56286. Another secondary objective is to evaluate the safety and tolerability of TEV-56286. The planned study period per participant is 56 weeks including a screening period (up to 4 weeks), a 48-week double-blind treatment period, and a follow-up visit (approximately 4 weeks after the end of the double-blind treatment period). The study duration will be approximately 27 months.
Conditions
- Multiple System Atrophy
Interventions
TEV-56286Drug
TEV-56286 capsules administered orally
PlaceboDrug
Matching placebo administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- For non-EU: Change From Baseline in the Modified Unified Multiple System Atrophy Rating Scale (UMSARS) Part I Score (excluding item 11)Time frame: Baseline to Week 48
- For EU: Change From Baseline in the Total UMSARS Score Part I and Part II CombinedTime frame: Baseline to Week 48
Locations
61 sites in 8 countries. Site status is shown where the registry gives one.
University of California - San Diego
La Jolla, California
University California Los Angeles Medical Center (Ucla)
Los Angeles, California
MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH)
Washington D.C., District of Columbia
Parkinson's Disease And Movement Disorder Center Of Boca Raton
Boca Raton, Florida
University of South Florida Parkinson's Disease and Movement Disorders Center
Tampa, Florida
Rush University Medical Center-Allergy/ Immunology Center
Chicago, Illinois
University of Kansas Medical Center
Kansas City, Kansas
Brigham and Women's Hospital
Boston, Massachusetts
Detroit Clinical Research Center, PC
Farmington Hills, Michigan
Mayo Clinic
Rochester, Minnesota
NYU Medical Center - Dysautonomia center
New York, New York
Columbia University Medical Center - The Neurological Institute of New York
New York, New York
Duke University School of Medicine - Duke Neurological Disorders Clinic - Morreene Road Location
Durham, North Carolina
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania
University Of Pittsburgh
Pittsburgh, Pennsylvania
Vanderbilt University Medical Center (VUMC)
Nashville, Tennessee
Texas Movement Disorder Specialists
Georgetown, Texas
Integrated Neurology Services
Alexandria, Virginia
Inland Northwest Research
Spokane, Washington
Centre Hospitalier Universitaire (CHU) de Bordeaux
Bordeaux, France
CHU de Caen
Caen, France
CHU - Hospital de la Timone
Marseille, France
Chu De La Pitie-Salpetriere
Paris, France
Centre Hospitalier Universitaire de Toulouse - Hopital Purpan
Toulouse, France
Kliniken Beelitz GmbH - Neurologisches Fachkrankenhaus fuer Bewegungsstoerungen / Parkinson
Beelitz, Germany
Universitatsklinikum Carl Gustav Carus an der Technischen Universitat Dresden
Dresden, Germany
University Hospital Duesseldorf
Düsseldorf, Germany
Paracelsus-Elena-Klinik
Kassel, Germany
Universitaetsklinikum Leipzig
Leipzig, Germany
Universitatsklinikum Giessen und Marburg GmbH
Marburg, Germany
LMU - Klinikum der Universitaet Muenchen - Campus Grosshadern
München, Germany
Universitaetsklinikum Muenster
Münster, Germany
University Of Ulm
Ulm, Germany
Rambam Health Care Campus (RHCC)
Haifa, Israel
Shaare Zedek Medical Center
Jerusalem, Israel
The Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
IRCCS Institute of Neurological Sciences of Bologna- Universita di Bologna
Bologna, Italy
Clinica Neurologica-Aou Policlinico-Vittorio Emanuele-Po G. Rodolico
Catania, Italy
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele (HSR) (Istituto Scientifico Universitario Sa
Milan, Italy
Azienda Ospedale Universita Padova
Padova, Italy
Showing 40 of 61 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.